We are live on ! Find out more
CCM

Chiron Capital Management Portfolio holdings

AUM $111M
This Fund
S&P 500
This Quarter Est. Return
+11.54%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$113M
AUM Growth
+$8.24M
Cap. Flow
-$2.92M
Cap. Flow %
-2.58%
Top 10 Hldgs %
45.09%
Holding
127
New
14
Increased
37
Reduced
52
Closed
8

Top Buys

Rank Stock Value
1
SLB icon
SLB Ltd
SLB
+$835K
2
NKE icon
Nike
NKE
+$781K
3
EL icon
Estee Lauder
EL
+$541K
4
DOW icon
Dow Inc
DOW
+$348K
5
RIO icon
Rio Tinto
RIO
+$328K

Top Sells

Rank Stock Value
1
SBUX icon
Starbucks
SBUX
+$901K
2
CCI icon
Crown Castle
CCI
+$846K
3
GILD icon
Gilead Sciences
GILD
+$641K
4
K
Kellanova
K
+$577K
5
UL icon
Unilever
UL
+$510K

Sector Composition

Rank Sector Weight
1 Healthcare 30.95%
2 Consumer Discretionary 9.17%
3 Consumer Staples 8.5%
4 Financials 8.23%
5 Energy 6.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BMY icon
1
Bristol-Myers Squibb
BMY
$127B
$23M 20.36%
444,606
-7,778
-2% -$365K
XBI icon
2
State Street SPDR S&P Biotech ETF
XBI
$10.1B
$8.78M 7.77%
88,905
-2,449
-3% -$241K
NKE icon
3
Nike
NKE
$61.9B
$3.36M 2.97%
37,962
+9,953
+36% +$781K
AFL icon
4
Aflac
AFL
$63.9B
$2.6M 2.3%
23,258
+203
+0.9% +$20.6K
CVS icon
5
CVS Health
CVS
$137B
$2.55M 2.26%
40,530
-1,097
-3% -$64K
GILD icon
6
Gilead Sciences
GILD
$161B
$2.42M 2.14%
28,877
-8,398
-23% -$641K
AAPL icon
7
Apple
AAPL
$4.89T
$2.28M 2.02%
9,793
+1,050
+12% +$234K
EPD icon
8
Enterprise Products Partners
EPD
$83.8B
$2.06M 1.83%
70,859
-1,414
-2% -$41.3K
PFE icon
9
Pfizer
PFE
$140B
$1.98M 1.75%
68,270
-1,716
-2% -$50.1K
FTGC icon
10
First Trust Global Tactical Commodity Strategy Fund
FTGC
$2.99B
$1.91M 1.69%
80,503
+4,013
+5% +$93.1K
EL icon
11
Estee Lauder
EL
$29B
$1.89M 1.67%
18,915
+5,702
+43% +$541K
SDVD icon
12
FT Vest SMID Rising Dividend Achievers Target Income ETF
SDVD
$909M
$1.85M 1.64%
83,782
+9,912
+13% +$213K
ET icon
13
Energy Transfer Partners
ET
$70.1B
$1.76M 1.55%
109,406
-3,594
-3% -$57.8K
T icon
14
AT&T
T
$165B
$1.63M 1.44%
73,910
-7,305
-9% -$145K
SHW icon
15
Sherwin-Williams
SHW
$78.3B
$1.53M 1.35%
4,008
+8
+0.2% +$2.79K
MDT icon
16
Medtronic
MDT
$107B
$1.48M 1.31%
16,405
-4,382
-21% -$369K
MCD icon
17
McDonald's
MCD
$188B
$1.39M 1.23%
4,558
-1,395
-23% -$384K
KHC icon
18
Kraft Heinz
KHC
$30.4B
$1.37M 1.22%
39,112
-497
-1% -$17.1K
ALB icon
19
Albemarle
ALB
$13.5B
$1.24M 1.1%
13,109
+1,100
+9% +$97.7K
XOM icon
20
ExxonMobil
XOM
$651B
$1.23M 1.09%
10,468
-446
-4% -$51.5K
FTSM icon
21
First Trust Enhanced Short Maturity ETF
FTSM
$6.51B
$1.17M 1.03%
19,481
+370
+2% +$22.2K
MSFT icon
22
Microsoft
MSFT
$2.84T
$1.12M 0.99%
2,609
+343
+15% +$147K
RJF icon
23
Raymond James Financial
RJF
$32.5B
$1.06M 0.94%
8,650
DG icon
24
Dollar General
DG
$25.9B
$1.03M 0.91%
12,200
+2,000
+20% +$219K
HD icon
25
Home Depot
HD
$332B
$984K 0.87%
2,430
+225
+10% +$82.1K

Similar funds

Chiron Capital Management's Q3 2024 Portfolio in Review

As of Q3 2024, Chiron Capital Management held 127 positions worth $113M, up 7.9% from $105M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Chiron Capital Management's Q3 2024 filing shows 14 new, 37 increased, 52 reduced and 8 closed positions. Its largest new stake was SLB Ltd: 18,761 shares worth $787K. The largest sale was Starbucks, an estimated $901K.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 30% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

  • Chiron Capital Management's largest Q3 2024 buy was SLB Ltd: 18,761 shares worth $787K.
  • Chiron Capital Management added most to Nike in Q3 2024, an estimated $781K increase.
  • Chiron Capital Management's biggest Q3 2024 reduction was Starbucks, cutting an estimated $901K.
  • Chiron Capital Management fully exited Kellanova in Q3 2024, selling an estimated $577K.
  • Chiron Capital Management's ten largest holdings make up 45% of its $113M portfolio in Q3 2024.
  • Chiron Capital Management opened 14 new positions and closed 8 in Q3 2024.
  • Chiron Capital Management's portfolio value rose 7.9% quarter-over-quarter to $113M.

Based on Chiron Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.